Stratified medicine approaches for the treatment of musculoskeletal disorders

Current Opinion in Pharmacology

Volumn 16, Issue 1, 2014, Pages 127-132

  Hocking, Lynne J ^a   Rivadeneira, Fernando ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; TUMOR NECROSIS FACTOR ANTIBODY; ZOLEDRONIC ACID; BIOLOGICAL MARKER;

ALBERS SCHOENBERG DISEASE; ARTICLE; DRUG RESEARCH; DRUG SAFETY; GENE MUTATION; GENETIC RISK; HUMAN; INTERVENTION STUDY; LIVER DYSFUNCTION; MEDICINE; MUSCULOSKELETAL DISEASE; NAUSEA; OSTEOPOROSIS; PAGET BONE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK REDUCTION; STRATIFIED MEDICINE; TREATMENT RESPONSE; GENETICS; METABOLISM; MUSCULOSKELETAL DISEASES;

BIOLOGICAL MARKERS; HUMANS; MUSCULOSKELETAL DISEASES;

EID: 84901771153     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.05.003     Document Type: Review

References (42)

1. S.J.H. Vijverberg, and A.-H. Maitland-van der Zee Pharmacogenetics and stratified medicine. Background paper 7.4 2013 1 38 WHO Collaborating Centre for Pharmaceutical Policy and Regulation [accessed 02.03.14]
2. K. Malottki, M. Biswas, J.J. Deeks, R.D. Riley, C. Craddock, P. Johnson, and L. Billingham Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers BMJ Open 4 2014 e004188
3. N. Harvey, E. Dennison, and C. Cooper Osteoporosis: impact on health and economics Nat Rev Rheumatol 6 2010 99 105
4. T. Vos, A.D. Flaxman, M. Naghavi, R. Lozano, C. Michaud, M. Ezzati, K. Shibuya, J.A. Salomon, S. Abdalla, V. Aboyans, J. Abraham, I. Ackerman, R. Aggarwal, S.Y. Ahn, M.K. Ali, M. Alvarado, H.R. Anderson, L.M. Anderson, K.G. Andrews, C. Atkinson, L.M. Baddour, A.N. Bahalim, S. Barker-Collo, L.H. Barrero, D.H. Bartels, M.G. Basanez, A. Baxter, M.L. Bell, E.J. Benjamin, D. Bennett, E. Bernabe, K. Bhalla, B. Bhandari, B. Bikbov, A.A. Bin, G. Birbeck, J.A. Black, H. Blencowe, J.D. Blore, F. Blyth, I. Bolliger, A. Bonaventure, S. Boufous, R. Bourne, M. Boussinesq, T. Braithwaite, C. Brayne, L. Bridgett, S. Brooker, P. Brooks, T.S. Brugha, C. Bryan-Hancock, C. Bucello, R. Buchbinder, G. Buckle, C.M. Budke, M. Burch, P. Burney, R. Burstein, B. Calabria, B. Campbell, C.E. Canter, H. Carabin, J. Carapetis, L. Carmona, C. Cella, F. Charlson, H. Chen, A.T. Cheng, D. Chou, S.S. Chugh, L.E. Coffeng, S.D. Colan, S. Colquhoun, K.E. Colson, J. Condon, M.D. Connor, L.T. Cooper, M. Corriere, M. Cortinovis, K.C. de Vaccaro, W. Couser, B.C. Cowie, M.H. Criqui, M. Cross, K.C. Dabhadkar, M. Dahiya, N. Dahodwala, J. Damsere-Derry, G. Danaei, A. Davis, L.D. De, L. Degenhardt, R. Dellavalle, A. Delossantos, J. Denenberg, S. Derrett, D.C. Des Jarlais, S.D. Dharmaratne, M. Dherani, C. Diaz-Torne, H. Dolk, E.R. Dorsey, T. Driscoll, H. Duber, B. Ebel, K. Edmond, A. Elbaz, S.E. Ali, H. Erskine, P.J. Erwin, P. Espindola, S.E. Ewoigbokhan, F. Farzadfar, V. Feigin, D.T. Felson, A. Ferrari, C.P. Ferri, E.M. Fevre, M.M. Finucane, S. Flaxman, L. Flood, K. Foreman, M.H. Forouzanfar, F.G. Fowkes, R. Franklin, M. Fransen, M.K. Freeman, B.J. Gabbe, S.E. Gabriel, E. Gakidou, H.A. Ganatra, B. Garcia, F. Gaspari, R.F. Gillum, G. Gmel, R. Gosselin, R. Grainger, J. Groeger, F. Guillemin, D. Gunnell, R. Gupta, J. Haagsma, H. Hagan, Y.A. Halasa, W. Hall, D. Haring, J.M. Haro, J.E. Harrison, R. Havmoeller, R.J. Hay, H. Higashi, C. Hill, B. Hoen, H. Hoffman, P.J. Hotez, D. Hoy, J.J. Huang, S.E. Ibeanusi, K.H. Jacobsen, S.L. James, D. Jarvis, R. Jasrasaria, S. Jayaraman, N. Johns, J.B. Jonas, G. Karthikeyan, N. Kassebaum, N. Kawakami, A. Keren, J.P. Khoo, C.H. King, L.M. Knowlton, O. Kobusingye, A. Koranteng, R. Krishnamurthi, R. Lalloo, L.L. Laslett, T. Lathlean, J.L. Leasher, Y.Y. Lee, J. Leigh, S.S. Lim, E. Limb, J.K. Lin, M. Lipnick, S.E. Lipshultz, W. Liu, M. Loane, S.L. Ohno, R. Lyons, J. Ma, J. Mabweijano, M.F. MacIntyre, R. Malekzadeh, L. Mallinger, S. Manivannan, W. Marcenes, L. March, D.J. Margolis, G.B. Marks, R. Marks, A. Matsumori, R. Matzopoulos, B.M. Mayosi, J.H. McAnulty, M.M. McDermott, N. McGill, J. McGrath, M.E. Medina-Mora, M. Meltzer, G.A. Mensah, T.R. Merriman, A.C. Meyer, V. Miglioli, M. Miller, T.R. Miller, P.B. Mitchell, A.O. Mocumbi, T.E. Moffitt, A.A. Mokdad, L. Monasta, M. Montico, M. Moradi-Lakeh, A. Moran, L. Morawska, R. Mori, M.E. Murdoch, M.K. Mwaniki, K. Naidoo, M.N. Nair, L. Naldi, K.M. Narayan, P.K. Nelson, R.G. Nelson, M.C. Nevitt, C.R. Newton, S. Nolte, P. Norman, R. Norman, M. O'Donnell, S. O'Hanlon, C. Olives, S.B. Omer, K. Ortblad, R. Osborne, D. Ozgediz, A. Page, B. Pahari, J.D. Pandian, A.P. Rivero, S.B. Patten, N. Pearce, R.P. Padilla, and F. Perez-Ruiz Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2163 2196
5. M.R. Trusheim, E.R. Berndt, and F.L. Douglas Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers Nat Rev Drug Discov 6 2007 287 293 (Pubitemid 46505879)
6. U.I. Schwarz, M.D. Ritchie, Y. Bradford, C. Li, S.M. Dudek, A. Frye-Anderson, R.B. Kim, D.M. Roden, and C.M. Stein Genetic determinants of response to warfarin during initial anticoagulation N Engl J Med 358 2008 999 1008 (Pubitemid 351347099)
7. S. Saevarsdottir, H. Wallin, M. Seddighzadeh, S. Ernestam, P. Geborek, I.F. Petersson, J. Bratt, and R.F. van Vollenhoven Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial Ann Rheum Dis 70 2011 469 475
8. J.A. Kanis, O. Johnell, A. Oden, H. Johansson, and E: McCloskey FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 2008 385 397
9. S.L. Mackie, J.C. Taylor, S. Twigg, S.G. Martin, S. Steer, J. Worthington, A. Barton, A.G. Wilson, L. Hocking, A. Young, P. Emery, J.H. Barrett, and A.W. Morgan Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional study Ann Rheum Dis 71 2012 1640 1645
10. F.J. Accurso, S.M. Rowe, J.P. Clancy, M.P. Boyle, J.M. Dunitz, P.R. Durie, S.D. Sagel, D.B. Hornick, M.W. Konstan, S.H. Donaldson, R.B. Moss, J.M. Pilewski, R.C. Rubenstein, A.Z. Uluer, M.L. Aitken, S.D. Freedman, L.M. Rose, N. Mayer-Hamblett, Q. Dong, J. Zha, A.J. Stone, E.R. Olson, C.L. Ordonez, P.W. Campbell, M.A. Ashlock, and B.W. Ramsey Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation N Engl J Med 363 2010 1991 2003
11. B.P. O'Sullivan, D.M. Orenstein, and C.E. Milla Pricing for orphan drugs: will the market bear what society cannot? JAMA 310 2013 1343 1344
12. C. Sobacchi, A. Schulz, F.P. Coxon, A. Villa, and M.H. Helfrich Osteopetrosis: genetics, treatment and new insights into osteoclast function Nat Rev Endocrinol 9 2013 522 536
13. N. Laurin, J.P. Brown, J. Morissette, and V. Raymond Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone Am J Hum Genet 70 2002 1582 1588 (Pubitemid 34533906)
14. L.J. Hocking, G.J. Lucas, A. Daroszewska, J. Mangion, M. Olavesen, T. Cundy, G.C. Nicholson, L. Ward, S.T. Bennett, W. Wuyts, H.W. Van, and S.H. Ralston Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease Hum Mol Genet 11 2002 2735 2739 (Pubitemid 35214900)
15. M.H. Helfrich, and L.J. Hocking Genetics and aetiology of Pagetic disorders of bone Arch Biochem Biophys 473 2008 172 182
16. L.J. Hocking, G.J. Lucas, A. Daroszewska, T. Cundy, G.C. Nicholson, J. Donath, J.P. Walsh, C. Finlayson, J.R. Cavey, B. Ciani, P.W. Sheppard, M.S. Searle, R. Layfield, and S.H. Ralston Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences J Bone Miner Res 19 2004 1122 1127 (Pubitemid 41110564)
17. M.R. Visconti, A.L. Langston, N. Alonso, K. Goodman, P.L. Selby, W.D. Fraser, and S.H. Ralston Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone J Bone Miner Res 25 2010 2368 2373
18. C. Curtis, S.P. Shah, S.F. Chin, G. Turashvili, O.M. Rueda, M.J. Dunning, D. Speed, A.G. Lynch, S. Samarajiwa, Y. Yuan, S. Graf, G. Ha, G. Haffari, A. Bashashati, R. Russell, S. McKinney, A. Langerod, A. Green, E. Provenzano, G. Wishart, S. Pinder, P. Watson, F. Markowetz, L. Murphy, I. Ellis, A. Purushotham, A.L. Borresen-Dale, J.D. Brenton, S. Tavare, C. Caldas, and S. Aparicio The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature 486 2012 346 352
19. Y. Nagai, and T. Imanishi RAvariome: a genetic risk variants database for rheumatoid arthritis based on assessment of reproducibility between or within human populations Database (Oxford) 2013 bat073
20. M. Schneider, and K. Kruger Rheumatoid arthritis - early diagnosis and disease management Dtsch Arztebl Int 110 2013 477 484
21. L.M. da Mota, L.L. Dos Santos Neto, J.F. de Carvalho, I.A. Pereira, R. Burlingame, H.A. Menard, and I.M. Laurindo The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years Rheumatol Int 32 2012 3807 3812
22. A. Yarwood, B. Han, S. Raychaudhuri, J. Bowes, M. Lunt, D.A. Pappas, J. Kremer, J.D. Greenberg, R. Plenge, J. Worthington, A. Barton, and S. Eyre A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk Ann Rheum Dis 2013
23. M.T. Maehlen, I.C. Olsen, B.K. Andreassen, M.K. Viken, X. Jiang, L. Alfredsson, H. Kallberg, B. Brynedal, F. Kurreeman, N. Daha, R. Toes, A. Zhernakova, J. Gutierrez-Achury, P.I. de Bakker, J. Martin, M. Teruel, M.A. Gonzalez-Gay, L. Rodriguez-Rodriguez, A. Balsa, T. Uhlig, T.K. Kvien, and B.A. Lie Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis Ann Rheum Dis 2013
24. J.A. Sparks, C.Y. Chen, X. Jiang, J. Askling, L.T. Hiraki, S. Malspeis, L. Klareskog, L. Alfredsson, K.H. Costenbader, and E.W. Karlson Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history Ann Rheum Dis 2014
25. K.I. Halilova, E.E. Brown, S.L. Morgan, S.L. Bridges Jr., M.H. Hwang, D.K. Arnett, and M.I. Danila Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand? Int J Rheumatol 2012 2012 978396
26. C. Wagner, D. Chen, H. Fan, E.C. Hsia, M. Mack, P. Emery, and R.M. Fleischmann Evaluation of serum biomarkers associated with radiographic progression in methotrexate-naive rheumatoid arthritis patients treated with methotrexate or golimumab J Rheumatol 40 2013 590 598
27. M.C. de Rotte, P.H. de Jong, S.M. Pluijm, M.B. Calasan, P.J. Barendregt, Z.D. van, P.A. van der Lubbe, P.B. de Sonnaville, J. Lindemans, J.M. Hazes, and J.R. de Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate Arthritis Rheum 65 2013 2803 2813
28. S.R. Kapoor, A. Filer, M.A. Fitzpatrick, B.A. Fisher, P.C. Taylor, C.D. Buckley, I.B. McInnes, K. Raza, and S.P. Young Metabolic profiling predicts response to anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis Arthritis Rheum 65 2013 1448 1456
29. D. Plant, A.G. Wilson, and A. Barton Genetic and epigenetic predictors of responsiveness to treatment in RA Nat Rev Rheumatol 2014
30. V.C. Romao, H. Canhao, and J.E. Fonseca Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med 11 2013 17
31. X. Ma, and S. Xu TNF inhibitor therapy for rheumatoid arthritis Biomed Rep 1 2013 177 184
32. D. Plant, J. Bowes, C. Potter, K.L. Hyrich, A.W. Morgan, A.G. Wilson, J.D. Isaacs, and A. Barton Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci Arthritis Rheum 63 2011 645 653
33. M.M. Umicevic, J. Cui, S.H. Vermeulen, E.A. Stahl, E.J. Toonen, R.R. Makkinje, A.T. Lee, T.W. Huizinga, R. Allaart, A. Barton, X. Mariette, C.R. Miceli, L.A. Criswell, P.P. Tak, V.N. de, S. Saevarsdottir, L. Padyukov, S.L. Bridges, D.J. van Schaardenburg, T.L. Jansen, E.A. Dutmer, M.A. van de Laar, P. Barrera, T.R. Radstake, P.L. van Riel, H. Scheffer, B. Franke, H.G. Brunner, R.M. Plenge, P.K. Gregersen, H.J. Guchelaar, and M.J. Coenen Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis Ann Rheum Dis 72 2013 1375 1381
34. R.M. Plenge, J.D. Greenberg, L.M. Mangravite, J.M. Derry, E.A. Stahl, M.J. Coenen, A. Barton, L. Padyukov, L. Klareskog, P.K. Gregersen, X. Mariette, L.W. Moreland, S.L. Bridges Jr., V.N. de, T.W. Huizinga, H.J. Guchelaar, S.H. Friend, and G. Stolovitzky Crowdsourcing genetic prediction of clinical utility in the rheumatoid arthritis responder challenge Nat Genet 45 2013 468 469
35. R.M. Aspden, B.A. Scheven, and J.D. Hutchison Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism Lancet 357 2001 1118 1120 (Pubitemid 32322547)
36. J.Y. Reginster, J. Badurski, N. Bellamy, W. Bensen, R. Chapurlat, X. Chevalier, C. Christiansen, H. Genant, F. Navarro, E. Nasonov, P.N. Sambrook, T.D. Spector, and C. Cooper Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial Ann Rheum Dis 72 2013 179 186
37. O. Bruyere, J.Y. Reginster, N. Bellamy, R. Chapurlat, P. Richette, and C. Cooper Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis Rheumatology (Oxford) 2014
38. S. Tenti, S. Cheleschi, G.M. Guidelli, M. Galeazzi, and A. Fioravanti What about strontium ranelate in osteoarthritis? Doubts and securities Mod Rheumatol 2014
39. E. Suresh, M. Pazianas, and B. Abrahamsen Safety issues with bisphosphonate therapy for osteoporosis Rheumatology (Oxford) 53 2014 19 31
40. F. Rivadeneira, U. Styrkarsdottir, K. Estrada, B.V. Halldorsson, Y.H. Hsu, J.B. Richards, M.C. Zillikens, F.K. Kavvoura, N. Amin, Y.S. Aulchenko, L.A. Cupples, P. Deloukas, S. Demissie, E. Grundberg, A. Hofman, A. Kong, D. Karasik, J.B. van Meurs, B. Oostra, T. Pastinen, H.A. Pols, G. Sigurdsson, N. Soranzo, G. Thorleifsson, U. Thorsteinsdottir, F.M. Williams, S.G. Wilson, Y. Zhou, S.H. Ralston, C.M. van Duijn, T. Spector, D.P. Kiel, K. Stefansson, J.P. Ioannidis, and A.G. Uitterlinden Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies Nat Genet 41 2009 1199 1206
41. K. Estrada, U. Styrkarsdottir, E. Evangelou, Y.H. Hsu, E.L. Duncan, E.E. Ntzani, L. Oei, O.M. Albagha, N. Amin, J.P. Kemp, D.L. Koller, G. Li, C.T. Liu, R.L. Minster, A. Moayyeri, L. Vandenput, D. Willner, S.M. Xiao, L.M. Yerges-Armstrong, H.F. Zheng, N. Alonso, J. Eriksson, C.M. Kammerer, S.K. Kaptoge, P.J. Leo, G. Thorleifsson, S.G. Wilson, J.F. Wilson, V. Aalto, M. Alen, A.K. Aragaki, T. Aspelund, J.R. Center, Z. Dailiana, D.J. Duggan, M. Garcia, N. Garcia-Giralt, S. Giroux, G. Hallmans, L.J. Hocking, L.B. Husted, K.A. Jameson, R. Khusainova, G.S. Kim, C. Kooperberg, T. Koromila, M. Kruk, M. Laaksonen, A.Z. Lacroix, S.H. Lee, P.C. Leung, J.R. Lewis, L. Masi, S. Mencej-Bedrac, T.V. Nguyen, X. Nogues, M.S. Patel, J. Prezelj, L.M. Rose, S. Scollen, K. Siggeirsdottir, A.V. Smith, O. Svensson, S. Trompet, O. Trummer, N.M. van Schoor, J. Woo, K. Zhu, S. Balcells, M.L. Brandi, B.M. Buckley, S. Cheng, C. Christiansen, C. Cooper, G. Dedoussis, I. Ford, M. Frost, D. Goltzman, J. Gonzalez-Macias, M. Kahonen, M. Karlsson, E. Khusnutdinova, J.M. Koh, P. Kollia, B.L. Langdahl, W.D. Leslie, P. Lips, O. Ljunggren, R.S. Lorenc, J. Marc, D. Mellstrom, B. Obermayer-Pietsch, J.M. Olmos, U. Pettersson-Kymmer, D.M. Reid, J.A. Riancho, P.M. Ridker, F. Rousseau, P.E. Slagboom, N.L. Tang, R. Urreizti, H.W. Van, J. Viikari, M.T. Zarrabeitia, Y.S. Aulchenko, M. Castano-Betancourt, E. Grundberg, L. Herrera, T. Ingvarsson, H. Johannsdottir, T. Kwan, R. Li, R. Luben, C. Medina-Gomez, S.T. Palsson, S. Reppe, J.I. Rotter, G. Sigurdsson, J.B. van Meurs, D. Verlaan, F.M. Williams, A.R. Wood, Y. Zhou, K.M. Gautvik, T. Pastinen, S. Raychaudhuri, J.A. Cauley, D.I. Chasman, G.R. Clark, S.R. Cummings, P. Danoy, E.M. Dennison, R. Eastell, J.A. Eisman, V. Gudnason, A. Hofman, R.D. Jackson, G. Jones, J.W. Jukema, K.T. Khaw, T. Lehtimaki, Y. Liu, M. Lorentzon, E. McCloskey, B.D. Mitchell, K. Nandakumar, G.C. Nicholson, B.A. Oostra, M. Peacock, H.A. Pols, R.L. Prince, O. Raitakari, I.R. Reid, J. Robbins, P.N. Sambrook, P.C. Sham, A.R. Shuldiner, F.A. Tylavsky, C.M. van Duijn, N.J. Wareham, L.A. Cupples, M.J. Econs, D.M. Evans, T.B. Harris, A.W. Kung, B.M. Psaty, J. Reeve, T.D. Spector, E.A. Streeten, M.C. Zillikens, U. Thorsteinsdottir, C. Ohlsson, D. Karasik, J.B. Richards, M.A. Brown, K. Stefansson, A.G. Uitterlinden, S.H. Ralston, J.P. Ioannidis, D.P. Kiel, and F. Rivadeneira Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture Nat Genet 44 2012 491 501
42. C. Medina-Gomez, J.P. Kemp, K. Estrada, J. Eriksson, J. Liu, S. Reppe, D.M. Evans, D.H. Heppe, L. Vandenput, L. Herrera, S.M. Ring, C.J. Kruithof, N.J. Timpson, M.C. Zillikens, O.K. Olstad, H.F. Zheng, J.B. Richards, P.B. St, A. Hofman, V.W. Jaddoe, G.D. Smith, M. Lorentzon, K.M. Gautvik, A.G. Uitterlinden, R. Brommage, C. Ohlsson, J.H. Tobias, and F. Rivadeneira Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus PLoS Genet 8 2012 e1002718